SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-004315
Filing Date
2015-05-14
Accepted
2015-05-14 16:27:52
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q admp-10q_20150331.htm 10-Q 732121
2 EX-31.1 admp-ex311_201503318.htm EX-31.1 14163
3 EX-31.2 admp-ex312_201503319.htm EX-31.2 14097
4 EX-32.1 admp-ex321_2015033110.htm EX-32.1 4398
5 EX-32.2 admp-ex322_2015033111.htm EX-32.2 4405
  Complete submission text file 0001564590-15-004315.txt   4888093

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT admp-20150331.xml EX-101.INS 718888
7 XBRL TAXONOMY EXTENSION SCHEMA admp-20150331.xsd EX-101.SCH 31655
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE admp-20150331_cal.xml EX-101.CAL 27798
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE admp-20150331_def.xml EX-101.DEF 151196
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE admp-20150331_lab.xml EX-101.LAB 263467
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE admp-20150331_pre.xml EX-101.PRE 210165
Mailing Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36242 | Film No.: 15863239
SIC: 2834 Pharmaceutical Preparations